Adam R. Renslo, PhD

Phone: 415-514-9698
UCSF Box: 2552
Email: adam.renslo@ucsf.edu
UCSF Profile

Project Sponsor Location(s) Topics Start
End
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis University of Texas Health Science Center United States Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Identification of Anti-HIV Lead Compounds Targeting Advanced Genetic Systems, Inc. United States Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis Bill & Melinda Gates Foundation United States Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis University of Texas, Medical Branch at Galveston United States Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs)
Identification of Novel Therapeutics Molecules against Old and New World Cutaneous Leishmaniasis University of Texas, Medical Branch at Galveston United States Drug and Diagnostics Development
Chemical Methods for Ferrous Iron Targeted Drug Delivery NIH National Institute of Allergy and Infectious Disease United States
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease University of California San Diego (UCSD) Brazil Zoonosis, Emerging Disease, and Drug Resistance